Home / World Marketplace / Archive by category Global Health & Biotech (Page 80)

Archive by category Global Health & Biotech

Sandoz Acquires CIMERLI® Business from Coherus, Further Building Biosimilar and Ophthalmology Leadership in US Market

CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®** (ranibizumab injection) for all approved indications Dedicated retina sales and field reimbursement team integrated into Sandoz, ensuring seamless experience for providers and patients Basel, March 4, 2024 (Korea Bizwire) – Sandoz, the global leader in generic and biosimilar medicines, has completed the acquisition of the US biosimilar CIMERLI®* [...]

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the [...]

Bringing Confident Diagnosis to More Patients at Low Cost: Philips Launches New AI-enabled CT 5300 at #ECR2024

February 29, 2024 (Korea Bizwire) New CT 5300 system provides more accurate and reliable imaging results to better manage increase in complex cardiac cases where precise patient diagnosis is crucial Philips’ latest innovation leverages the power of AI at every stage in CT scanner operation to enhance productivity and diagnostic capabilities of high-throughput, short-staffed radiology departments [...]

Sandoz US Subsidiaries Resolve Generic Drug Antitrust Class Action Litigation with Direct Purchaser Class Plaintiffs

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Sandoz US to pay USD 265 million in exchange for full release of all claims by the class Resolves all federal antitrust damages for direct purchaser class plaintiffs’ claims in this litigation, if approved by Court Basel, February 29, 2024 – Sandoz [...]

Philips Extends Leadership in Virtually Helium-free MRI with More Than 1,000 Systems Installed, Expanding Patient Access Worldwide

February 28, 2024 (Korea Bizwire) At #ECR2024, company also debuting Europe’s first mobile virtually helium-free MRI system Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant milestone as it expands access to virtually helium-free [1] MRI to more patients in more places, with more [...]

Novotech Publishes Duchenne Muscular Dystrophy Landscape Report to Support Biotech Research Planning

BOSTON, Feb. 28, 2024 (Korea Bizwire) – Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today an industry-leading report on Duchenne Muscular Dystrophy (DMD) Clinical Trial Landscape. The report includes emerging genetic therapies, funding landscape, and a [...]

Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)

February 28, 2024 (Korea Bizwire) Proposal to appoint Ms. Hanneman as member of Philips’ Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the proposal to appoint Charlotte Hanneman as member of the Board of Management, [...]

Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients

February 27, 2024 (Korea Bizwire) New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced major enhancements to its Image Guided Therapy System – [...]

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Feb. 27, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: TD Cowen 44th Annual Health Care Conference: Zymeworks’ management will [...]

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results

Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense SAN DIEGO, Feb. 26, 2024 (Korea Bizwire) – Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible and rapid automated [...]